Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.

Authors: Emma Maria Viktoria Hyddmark, Donald A. Berry, Nicholas S. Berry, Howard Colman, John Frederick de Groot, Benjamin M. Ellingson, Hui Kong Gan, Adam Johnson, Andrew B. Lassman, Michael Lim, Ingo K. Mellinghoff, James R. Perry, Erik P. Sulman, Michael Weller, Patrick Y. Wen, Timothy Francis Cloughesy,

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2100

Source: Full article

---

Abstract

TPS2100